The latest update is out from PDS Biotechnology ( (PDSB) ).

Merck spent $10bn on lung disease-focused biotech Verona Pharma in July, its biggest acquisition in two years, amid concerns ...

The incidence of HPV16-related cancers is rapidly increasing in the US and Europe and also increasing globally.* PDS0101 is currently being studied in the Company’s Phase 3 trial for PDS0101 + ...

CHA Biotech subsidiary Matica Biolabs signed a contract to manufacture medical developer TiCARos' new CAR-T cancer therapy ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology ...

Exicure’s investigational small molecule succeeded in mobilizing key blood-forming cells in almost 90% of patients in a phase ...

A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...

Notably, the Huntsville site will be among those that will manufacture orforglipron, Lilly’s first oral, small molecule GLP-1 ...

Eli Lilly invests $6 billion in new drug manufacturing facility in Alabama, designed to expanding U.S. production and strengthening medicine supply chains.

The biotech announced a secondary stock issue. It aims to sell $300 million worth of common shares. 10 stocks we like better ...